APP and Alzheimer disease: Since its discovery, much of the research of the type 1 transmembrane protein β-amyloid precursor protein (APP) has focused on its proteolytic components, particularly the β-amyloid (Aβ) peptide that accumulates in Alzheimer’s disease.